文献速递传染病防控与疫情报告卫生政策与健康促进

重组犬弓蛔虫蛋白在小鼠弓蛔虫病模型中的免疫原性与保护效果

Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis.
PubMed 文献 · Vaccine · 2020-05-23

本研究通过计算机模拟和幼虫蛋白质组学分析鉴定出8个犬弓蛔虫重组蛋白候选疫苗,并在C57BL/6雌性小鼠模型中评估其中7个抗原的免疫原性与保护效果。所有7个分子均具免疫原性,其中rTcCad和rTcVcan使攻毒后幼虫负荷分别降低54.3%和53.9%(P<0.0001)。所有7个重组蛋白均能被犬弓蛔虫血清阳性犬和人血清识别。

要点

  • 计算机模拟鉴定的膜相关重组蛋白rTcCad和rTcVcan可显著降低攻毒后小鼠幼虫负荷。
  • 所有7个重组蛋白均能诱导特异性抗体和细胞因子反应,并被血清阳性犬和人血清识别。
  • rTcCad和rTcVcan是犬弓蛔虫病有前景的疫苗候选分子。

核心结论

  • 通过计算机模拟分析鉴定疫苗靶点是筛选能降低攻毒后幼虫负荷的犬弓蛔虫免疫原性蛋白的有效策略。
  • 重组蛋白rTcCad和rTcVcan被确定为犬弓蛔虫病有前景的疫苗候选分子。

研究设计与样本

  • 研究用计算机模拟分析(rTcGPRs、rTcCad、rTcVcan、rTcCyst)和幼虫蛋白质组学分析(rTES26、rTES32、rMUC-3、rCTL-4)鉴定8个犬弓蛔虫重组蛋白候选疫苗。
  • 在弓蛔虫病小鼠模型中评估其中7个抗原的免疫原性和抗感染攻击保护效果。
  • C57BL/6雌性小鼠免疫后以500个犬弓蛔虫含胚卵攻击,检测血清特异性抗体(IgG、IgG1、IgG2a、IgE)和脾细胞受抗原刺激产生的细胞因子(IL-5、IFN-γ、IL-10)。
  • 检测犬弓蛔虫血清阳性犬和人血清中对这些分子的特异性抗体。

主要发现

  • 所有7个分子在免疫小鼠中均具免疫原性,均显著升高特异性IgG、IgG1或IgG2a水平,其中6个与特异性IgE水平升高相关。
  • 所有分子均诱导脾细胞产生升高的IFN-γ和IL-10,但仅计算机模拟鉴定的膜相关重组蛋白(rTcCad、rTcVcan、rTcCyst)诱导显著升高的IL-5产生。
  • 与未免疫对照相比,rTcCad和rTcVcan免疫使攻击后小鼠幼虫负荷分别降低54.3%和53.9%(P<0.0001)。
  • 所有7个重组蛋白均能被犬弓蛔虫血清阳性犬和人血清识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Toxocariasis, a natural helminth infection of dogs and cats caused by Toxocara canis and T. cati, respectively, that are transmitted to mammals, including humans. Infection control is based currently on periodic antihelmintic treatment and there is a need for the development of vaccines to prevent this infection. MATERIALS AND METHODS: Eight potential vaccine candidate T. canis recombinant proteins were identified by in silico (rTcGPRs, rTcCad, rTcVcan, rTcCyst) and larval proteomics (rTES26, rTES32, rMUC-3 and rCTL-4) analyses. Immunogenicity and protection against infectious challenge for seven of these antigens were determined in a murine model of toxocariasis. C57BL/6 female mice were immunized with each of or combinations of recombinant antigens prior to challenge with 500 T. canis embryonated eggs. Levels of specific antibodies (IgG, IgG1, IgG2a and IgE) in sera and cytokines (IL-5, INF-ɣ and IL-10) produced by antigens-stimulated splenocytes, were measured. Presence of specific antibodies to the molecules was measured in sera of T. canis-seropositive dogs and humans. RESULTS: All seven molecules were immunogenic in immunized mice; all stimulated significantly elevated levels of specific IgG, IgG1 or IgG2a and six were associated with elevated levels of specific IgE; all induced elevated production of IFN- ɣ and IL-10 by splenocytes, but only the in silico-identified membrane-associated recombinants (rTcCad, rTcVcan, and rTcCyst) induced significantly increased IL-5 production. Vaccination with two of the latter (rTcCad and rTcVcan) reduced larval loads in the T. canis challenged mice by 54.3% and 53.9% (P < 0.0001), respectively, compared to unimmunized controls. All seven recombinants were recognized by T. canis-seropositive dog and human sera. CONCLUSION: The identification of vaccine targets by in silico analysis was an effective strategy to identify immunogenic T. canis proteins capable of reducing larval burdens following challenge with the parasite. Two recombinant proteins, rTcCad and rTcVcan, were identified as promising vaccine candidates for canine toxocariasis.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Salazar Garcés LF, Santiago LF, Santos SPO, et al. Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis. Vaccine. 2020. PMID: 32451213. doi:10.1016/j.vaccine.2020.04.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。